GH

EDX Medical partners with Guardant Health to distribute groundbreaking liquid biopsy tests for cancer in the UK and Nordic countries, improving patient outcomes...

October 5, 2023

News and Interview Alerts

Company Presentations

Time Finance Profits Surge, Book Grows 86% as New Strategy Targets £300m Lending

Q&As

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

Hardman & Co

ICG Enterprise Trust – Doubling realisations: sustainability and impact

9 February 2026

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Green News

Best UK and TSX Energy Shares 2026

9 February 2026

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

BrokerTalk

Time Finance Delivers Positive Interim Results, Signals Confidence for Future Growth – Cavendish

28 January 2026

Global Opportunities Trust: Cash builds as valuations rise | New Research

28 January 2026

Record plc Reports Strong Momentum and Record AUM – Panmure Liberum

27 January 2026

The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum

26 January 2026

Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research

23 January 2026

Funds

Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR)

9 February 2026

Victorian Plumbing Group set for strong growth as scale and efficiency improve, hails fund manager

9 February 2026

Yü Group backed for strong upside as Premier Miton highlights low valuation and market share gains

9 February 2026

Gervais Williams backs Ithaca Energy for sustained returns and exceptional dividend potential (LON:ITH)

9 February 2026

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights

9 February 2026

Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE

9 February 2026

Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings

9 February 2026

Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance

9 February 2026

Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE

9 February 2026

Search Results for: bojan

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Precision Oncology Frontier with Promising 11.76% Upside

September 29, 2025

Guardant Health, Inc. (GH) Stock Analysis: A Look at Its 30.90% Revenue Growth and What It Means for Investors

September 22, 2025

Guardant Health, Inc. (GH) Stock Analysis: High Buy Ratings and Promising Revenue Growth in Precision Oncology

September 8, 2025

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Diagnostics Frontier with 30.90% Revenue Growth

September 1, 2025

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Pioneer with a 30.9% Revenue Growth Surge

August 25, 2025

Guardant Health, Inc. (GH) Stock Analysis: Navigating a 30.90% Revenue Surge Amid a Challenging Valuation Landscape

August 18, 2025

Guardant Health (GH) Stock Analysis: A Promising Opportunity with 12.99% Upside Potential

August 11, 2025

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 47% Upside Potential in Precision Oncology

August 4, 2025

Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Ratings and 34% Potential Upside Highlight Growth Potential

July 28, 2025

Guardant Health, Inc. (GH) Stock Analysis: A 28.42% Potential Upside in the Precision Oncology Sector

July 21, 2025

Guardant Health, Inc. (GH) Stock Analysis: A Diagnostic Innovator with 18.73% Upside Potential

July 14, 2025

Guardant Health, Inc. (GH) Stock Analysis: A Healthcare Innovator with an 18% Upside Potential

July 7, 2025

Guardant Health, Inc. (GH) Stock Analysis: 17% Upside Potential Amidst Strong Buy Ratings

June 30, 2025

Guardant Health, Inc. (GH) Investor Outlook: Analysts See 21.41% Upside Potential

June 23, 2025

Guardant Health, Inc. (GH) Stock Analysis: Unlocking a 21% Potential Upside in Precision Oncology

June 16, 2025

Guardant Health, Inc. (GH) Stock Analysis: Navigating a 23.67% Potential Upside in the Dynamic Diagnostics Sector

June 9, 2025

Guardant Health, Inc. (GH) Stock Analysis: Exploring a 46.59% Upside Potential in Precision Oncology

June 2, 2025

Guardant Health, Inc. (GH) Stock Analysis: A Promising 56.7% Upside in Precision Oncology

May 26, 2025

EDX Medical signs agreement to distribute cancer genomic tests from Guardant Health

EDX Medical partners with Guardant Health to distribute groundbreaking liquid biopsy tests for cancer in the UK and Nordic countries, improving patient outcomes...